CNC

Centene Corporation Common Stock (CNC)

Stock · NYSE · Health Care

$69.16as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Centene Expands CHOICE Arrangements in Indiana, Ohio, Oklahoma. Centene has rolled out new benefit programs that support its CHOICE arrangements in Indiana, Ohio and Oklahoma, signaling a push to broaden its managed care footprint. Analysts note the company’s turnaround still has room to grow, and its target price remains well above the current level. The broader managed‑care landscape is also shifting, with UnitedHealth reporting higher margins but lower membership, a trend that may influence competitive dynamics.

Active signals

Support level
$64.91
Industry
Medical Specialities

What CNC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike34+2.6%59%
Bollinger Band Breakdown26-0.5%46%
Bollinger Band Breakout23-0.8%48%
200-Day Moving Average TouchActive now15-0.8%47%
Any 20-session window (baseline)+0.5%52%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About CNC

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as l…

Sector
Health Care
Industry
Medical Specialities
Employees
61,100

Fundamentals

1-day range
$69.87$71
Market cap
$31.71B
P/E (trailing)
—
P/E (forward)
13.20
EPS (trailing)
$-10.44
Dividend yield
—
Beta
1.09
Avg. volume
4.62M
52-week range
$31.63$70.37
Next earnings: October 27, 2026 · EPS estimate $0.10Before Openconfirmed

How Centene Corporation Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$194.78BOther$179.20B (92%)SG&A$12.90B (7%)Cost of Revenue$2.67B (1%)CNC

Source: 10-K filed Feb 17, 2026 · via SEC EDGAR / Finnhub

Gross Profit$192.11B(99%)
Operating Income-$7.62B(-4%)

Forecasts

18 analyst ratings

Buy 44%
Hold 52%
Sell 4%
1-year price forecast
High
$85
+22.9%
Median
$70.5
+1.9%
Low
$56
-19.0%

Centene Corporation Common Stock Competitors

Chosen by industry and closest market cap.

  • CNC
    Centene Corporation Common Stock
    $69.16
    ▼ 1.91%
    Market cap $31.71BP/E —
    $31.63$70.37
  • ILMN
    Illumina Inc. Common Stock
    $262.54
    ▼ 2.01%
    Market cap $29.25BP/E 48.62
    $88$309.35
  • DGX
    Quest Diagnostics Incorporated Common Stock
    $235
    ▼ 1.74%
    Market cap $26.32BP/E 24.67
    $171.18$248.84
  • LH
    Labcorp Holdings Inc. Common Stock
    $317.95
    ▼ 2.19%
    Market cap $25.96BP/E 25.55
    $244.52$341.8
  • NTRA
    Natera Inc. Common Stock
    $393.44
    ▼ 2.80%
    Market cap $38.01BP/E —
    $170.82$437.41
  • GH
    Guardant Health Inc. Common Stock
    $158.6
    ▼ 4.39%
    Market cap $21.15BP/E —
    $61$191.05
  • HUM
    Humana Inc. Common Stock
    $413.16
    ▼ 4.41%
    Market cap $44.10BP/E 39.25
    $163.11$456.5

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
12.5K
Disposed
186.3K

Institutional Ownership

March 31, 2026

Total shares held
464.52M
Total value held
$14.44B
Institutional holders
853
Top holders this quarter
  • Unknown39.82M
  • Unknown33.61M
  • Unknown31.23M
  • Unknown21.65M
  • Unknown14.09M
  • Unknown12.99M
  • Unknown10.62M
  • Unknown10.13M
  • Unknown10.04M
  • Unknown9.88M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.